Response to platinum-based therapies in second-line after immunotherapy in advanced or metastatic non-small-cell lung cancer PD-L1 ≥50.

Autor: Olivares-Hernández A; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Faculty of Medicine, University of Salamanca (USAL), Salamanca, Spain., Posado-Domínguez L; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Redondo-González JC; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Corvo-Félix L; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Bellido Hernández L; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Faculty of Medicine, University of Salamanca (USAL), Salamanca, Spain., Fonseca-Sánchez E; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Faculty of Medicine, University of Salamanca (USAL), Salamanca, Spain., Del Barco-Morillo E; Thoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca (CAUSA), Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Faculty of Medicine, University of Salamanca (USAL), Salamanca, Spain.

Publikováno v: Translational lung cancer research [Transl Lung Cancer Res] 2024 Oct 31; Vol. 13 (10), pp. 2649-2659. Date of Electronic Publication: 2024 Oct 24.

Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review.

Autor: Posado-Domínguez L; Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Figuero-Pérez L; Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Olivares-Hernández A; Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Chinchilla-Tábora L; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Pathology Department, University Hospital of Salamanca, Salamanca, Spain., Antunez-Plaza P; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Pathology Department, University Hospital of Salamanca, Salamanca, Spain., Rivas-Hernández R; Pathology Department, University Hospital of Salamanca, Salamanca, Spain., Martín-Galache M; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Pediatric Department, University Hospital of Salamanca, Salamanca, Spain., Redondo González JC; Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Fonseca Sánchez E; Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Faculty of Medicine, University of Salamanca, Salamanca, Spain.

Publikováno v: Chinese clinical oncology [Chin Clin Oncol] 2024 Jun; Vol. 13 (3), pp. 42. Date of Electronic Publication: 2024 Jun 01.